IG
Insider
II Robert C. Goeltz
Chief Financial OfficerII Robert C. Goeltz (Chief Financial Officer) filed 5 Form 4 reports in the trailing twelve months (0 purchases, 5 sales), most often in Arcus Biosciences, Inc. (RCUS). The largest single filing was $279K of RCUS (12,662 sh across 2 lots, as filed), executed Dec 16 2025.
Add to watchlistReturn, ttmiAverage return per filing, trailing twelve months
–
no purchases on file
Delay-adjustediThe same average, entered at disclosure dates
–
returns measure stock purchases only
Filings, ttm
5
0 buys · 5 sells
Median delay
–
execution → disclosure
Volume, ttmiDollar value disclosed in the trailing twelve months
$856K
shares × price, as filed
Last traded
May 11
Filed May 12
Median ADV $38.5M across their filed names
Open performance→Volume by month
Buys $0
Sells $856K
Shares × price, as filed · by filing month · past 24 months
Sectors filed on
Healthcare
5 filings
Sector per market data · by filing · past 12 months
Most traded names
RCUSRecent filings
RCUSSALE
Arcus Biosciences, Inc.
View filing →
$199K7,763 sh × $25.63
Exec May 11
Filed May 12 · 5:30 PM ET RCUSSALE Arcus Biosciences, Inc. View filing → $153K
6,552 sh × $23.38
Exec Dec 31 2025
Filed Jan 2 · 5:30 PM ET RCUSSALE Arcus Biosciences, Inc. View filing → $279K
12,662 sh across 2 lots
Exec Dec 16 2025
Filed Dec 18 2025 · 5:30 PM ET RCUSSALE Arcus Biosciences, Inc. View filing → $125K
5,000 sh × $25.00
Exec Nov 26 2025
Filed Nov 26 2025 · 5:30 PM ET RCUSSALE Arcus Biosciences, Inc. View filing → $100K
5,000 sh × $20.00
Exec Oct 28 2025
Filed Oct 29 2025 · 5:30 PM ET